As of 2025-10-19, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (0.55) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -1944.1%.
The range of the Relative Valuation is (0.71) - (0.35) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.2x - 39.9x | 37.0x |
| Forward P/E multiples | 15.6x - 16.9x | 16.2x |
| Fair Price | (0.71) - (0.35) | (0.55) |
| Upside | -2466.5% - -1269.4% | -1944.1% |
| Date | P/E |
| 2025-10-16 | -1.45 |
| 2025-10-15 | -1.20 |
| 2025-10-14 | -1.20 |
| 2025-10-10 | -1.20 |
| 2025-10-09 | -1.45 |
| 2025-10-08 | -1.20 |
| 2025-10-07 | -1.45 |
| 2025-10-06 | -1.45 |
| 2025-10-03 | -1.45 |
| 2025-10-02 | -1.69 |
| 2025-10-01 | -1.93 |
| 2025-09-30 | -0.72 |
| 2025-09-29 | -0.72 |
| 2025-09-24 | -0.96 |
| 2025-09-23 | -0.96 |
| 2025-09-22 | -0.72 |
| 2025-09-18 | -0.72 |
| 2025-09-17 | -0.72 |
| 2025-09-16 | -0.72 |
| 2025-09-15 | -0.72 |
| 2025-09-12 | -0.72 |
| 2025-09-11 | -0.72 |
| 2025-09-10 | -0.72 |
| 2025-09-09 | -0.72 |
| 2025-09-08 | -0.72 |
| 2025-09-05 | -0.72 |
| 2025-09-04 | -0.72 |
| 2025-09-02 | -0.72 |
| 2025-08-26 | -0.96 |
| 2025-08-25 | -0.96 |
| 2025-08-22 | -0.96 |
| 2025-08-19 | -0.96 |
| 2025-08-18 | -0.96 |
| 2025-08-15 | -0.72 |
| 2025-08-13 | -0.72 |
| 2025-08-12 | -0.72 |
| 2025-08-11 | -0.72 |
| 2025-08-07 | -0.96 |
| 2025-08-06 | -0.72 |
| 2025-08-05 | -0.96 |
| 2025-08-01 | -0.96 |
| 2025-07-31 | -0.72 |
| 2025-07-29 | -0.72 |
| 2025-07-28 | -0.96 |
| 2025-07-24 | -0.72 |
| 2025-07-22 | -0.96 |
| 2025-07-21 | -0.72 |